Alnylam Pharmaceuticals, Inc. (ALNY) vs Medline Inc. (MDLN)

MDLN leads on 6 of 11 compared metrics.

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 15, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Compare
Alnylam Pharmaceuticals, Inc. logo
ALNY
Alnylam Pharmaceuticals, Inc.
$37.54B
$281.19HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT
Medline Inc. logo
MDLN
Medline Inc.
$33.55B
$39.68HealthcareDelayed quote: Jul 15, 2026, 10:50 AM EDT

Total return — ALNY vs MDLN

growth of $100 · dividends reinvested · last 1y
ALNY -30.5%MDLN -5.7%MDLN compounded faster
80100120Start $1002026$70$94
ALNY MDLN

ALNY vs MDLN: by the numbers

  • •ALNY is the larger company ($37.54B vs $33.55B market cap).
  • •MDLN trades at the lower earnings multiple (31.95 vs 66.81 P/E).
  • •ALNY converts more revenue to profit (13.46% vs 3.31% net margin).

Which is better, ALNY or MDLN?

Metric tally: ALNY 5 · MDLN 6

It depends on what you're optimizing for:

ValueMDLN(lower P/E)
QualityALNY(higher ROIC)

Metrics side by side

Valuation

MetricALNYMDLN
P/E ratio66.8131.95●
Forward P/E37.9125.56●
P/S ratio9.071.09●
P/B ratio36.152.83●
EV / EBITDA47.6414.18●
FCF yield1.65%4.78%●

Profitability

MetricALNYMDLN
Gross margin80.89%●24.04%
Operating margin17.54%●7.04%
Net margin13.46%●3.31%
ROE53.68%●8.55%
ROIC13.74%●5.69%

Growth (annualized)

MetricALNYMDLN
Revenue CAGR (5Y)49.67%—
FCF CAGR (5Y)14.35%—
Total return CAGR (5Y)10.55%—

Frequently asked

Which is better, ALNY or MDLN?
It depends on your goal. value: MDLN (lower P/E); quality: ALNY (higher ROIC). Across all compared metrics, MDLN leads 6 to 5.
Is ALNY or MDLN cheaper?
On trailing earnings, MDLN is cheaper: ALNY trades at a 66.81 P/E and MDLN at 31.95.
Is ALNY or MDLN more profitable?
ALNY runs the higher net margin — ALNY at 13.46% versus MDLN at 3.31%.

Go deeper

Full ALNY analysisFull MDLN analysisInteractive comparison tool

Dig into the metrics

Alnylam Pharmaceuticals P/E ratioMedline P/E ratioAlnylam Pharmaceuticals dividend yieldMedline dividend yieldAlnylam Pharmaceuticals ROEMedline ROEAlnylam Pharmaceuticals operating marginMedline operating marginAlnylam Pharmaceuticals revenue growthMedline revenue growthAlnylam Pharmaceuticals free cash flowMedline free cash flow

Alnylam Pharmaceuticals & Medline appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest FCF Yield StocksBest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 15, 2026.